Rights and permissions
About this article
Cite this article
EU-Zulassung für Nintedanib bei chronisch progredient fibrosierenden interstitiellen Lungenerkrankungen . Pneumo News 12, 59–60 (2020). https://doi.org/10.1007/s15033-020-1903-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-020-1903-5